CLTA
Clathrin light chain A
Also known as: CLCA_HUMAN, Lca
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09496
- Gene
- CLTA
- Ensembl
- ENSG00000122705
- Chromosome
- 9
- Canonical length
- 248 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Golgi apparatus,Vesicles,Endosomes,Lysosomes
OverviewNCBI Gene
Clathrin is a large, soluble protein composed of heavy and light chains. It functions as the main structural component of the lattice-type cytoplasmic face of coated pits and vesicles which entrap specific macromolecules during receptor-mediated endocytosis. This gene encodes one of two clathrin light chain proteins which are believed to function as regulatory elements. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 8 and 12. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
248 residues, UniProt reviewed canonical sequence.
>P09496|CLTA
1 MAELDPFGAP AGAPGGPALG NGVAGAGEED PAAAFLAQQE SEIAGIENDE AFAILDGGAP
61 GPQPHGEPPG GPDAVDGVMN GEYYQESNGP TDSYAAISQV DRLQSEPESI RKWREEQMER
121 LEALDANSRK QEAEWKEKAI KELEEWYARQ DEQLQKTKAN NRVADEAFYK QPFADVIGYV
181 TNINHPCYSL EQAAEEAFVN DIDESSPGTE WERVARLCDF NPKSSKQAKD VSRMRSVLIS
241 LKQAPLVHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLTA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 230 nTPM
Expression across tissuesHPA
Tissue
- kidney: 230 nTPM
- spinal cord: 226 nTPM
- cerebral cortex: 205 nTPM
- esophagus: 199 nTPM
- midbrain: 197 nTPM
- ovary: 197 nTPM
Single-cell type
- syncytiotrophoblasts: 1,536 nCPM
- hofbauer cells: 1,406 nCPM
- esophageal apical cells: 1,201 nCPM
- cytotrophoblasts: 1,160 nCPM
- migrating cytotrophoblasts: 931 nCPM
- oocytes: 824 nCPM
Immune cell
- intermediate monocyte: 240 nTPM
- myeloid DC: 224 nTPM
- classical monocyte: 223 nTPM
- total PBMC: 210 nTPM
- plasmacytoid DC: 193 nTPM
- non-classical monocyte: 193 nTPM
Brain region
- white matter: 161 nTPM
- pons: 156 nTPM
- medulla oblongata: 145 nTPM
- cerebellum: 144 nTPM
- hypothalamus: 143 nTPM
- spinal cord: 141 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 0.8
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- clathrin coat assembly
- clathrin-dependent endocytosis
- intracellular protein transport
- synaptic vesicle endocytosis
Molecular functions
- clathrin heavy chain binding
- GTPase binding
- peptide binding
- protein-containing complex binding
- structural molecule activity
Cellular components
- clathrin coat
- clathrin coat of coated pit
- clathrin coat of trans-Golgi network vesicle
- clathrin complex
- clathrin vesicle coat
- clathrin-coated endocytic vesicle
- cytoplasmic vesicle
- cytosol
- endolysosome membrane
- endosome
- Golgi apparatus
- lysosome
- membrane
- plasma membrane
- postsynaptic endocytic zone
- presynaptic endocytic zone membrane
- spindle
- synaptic vesicle membrane
- trans-Golgi network membrane
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLTA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLTA as an antibody target. Whether an autoantibody or antibody against CLTA could matter depends on whether native CLTA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLTA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLTA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...